{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:57:53Z","timestamp":1762574273044,"version":"build-2065373602"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"DOI":"10.7759\/cureus.96338","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:53:21Z","timestamp":1762574001000},"source":"Crossref","is-referenced-by-count":0,"title":["Influence of Diabetes Mellitus on Metabolic and Hormonal Interactions Promoting Aggressive Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Afreen","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Tasleem","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avneet","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas A","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya N","family":"Sankhwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13536","article-title":"Risk of prostate cancer across different racial\/ethnic groups in men with diabetes: a retrospective cohort study","volume":"35","author":"Chen CB","year":"2018","unstructured":"Chen CB, Eurich DT, Majumdar SR, Johnson JA. Risk of prostate cancer across different racial\/ethnic groups in men with diabetes: a retrospective cohort study. Diabet Med. 2018, 35:107-11. 10.1111\/dme.13536","journal-title":"Diabet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-1046","article-title":"Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden","volume":"22","author":"Fall K","year":"2013","unstructured":"Fall K, Garmo H, Gudbj\u00f6rnsdottir S, Stattin P, Zethelius B. Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden. Cancer Epidemiol Biomarkers Prev. 2013, 22:1102-9. 10.1158\/1055-9965.EPI-12-1046","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0055-4","article-title":"Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish randomized study of screening for prostate cancer","volume":"118","author":"Murtola TJ","year":"2018","unstructured":"Murtola TJ, Vihervuori VJ, Lahtela J, Talala K, Taari K, Tammela TL, Auvinen A. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish randomized study of screening for prostate cancer. Br J Cancer. 2018, 118:1248-54. 10.1038\/s41416-018-0055-4","journal-title":"Br J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4236\/jdm.2017.74026","article-title":"Higher prevalence of prostate cancer among veterans with type-2 diabetes mellitus","volume":"7","author":"Yaturu S","year":"2017","unstructured":"Yaturu S, Benyamin N, Youngberg B, Marchese M. Higher prevalence of prostate cancer among veterans with type-2 diabetes mellitus. J Diabetes Mellitus. 2017, 7:316-20. 10.4236\/jdm.2017.74026","journal-title":"J Diabetes Mellitus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.22.9575","article-title":"Epidemiology, etiology, diagnosis and treatment of prostate cancer","volume":"15","author":"Daniyal M","year":"2014","unstructured":"Daniyal M, Siddiqui ZA, Akram M, Asif HM, Sultana S, Khan A. Epidemiology, etiology, diagnosis and treatment of prostate cancer. Asian Pac J Cancer Prev. 2014, 15:9575-8. 10.7314\/apjcp.2014.15.22.9575","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18203\/2349-2902.isj20181581","article-title":"Low endogenous testosterone level is associated with high-risk prostate specific antigen level in men with prostate cancer disease","volume":"5","author":"Amadi C","year":"2018","unstructured":"Amadi C, Odum EP, Aleme BM. Low endogenous testosterone level is associated with high-risk prostate specific antigen level in men with prostate cancer disease. Int Surg J. 2018, 5:1617-21. 10.18203\/2349-2902.isj20181581","journal-title":"Int Surg J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i6.1367","article-title":"Unraveling the biological link between diabetes mellitus and prostate cancer: Insights and implications","volume":"15","author":"Li J","year":"2024","unstructured":"Li J, Li ZP, Xu SS, Wang W. Unraveling the biological link between diabetes mellitus and prostate cancer: Insights and implications. World J Diabetes. 2024, 15:1367-73. 10.4239\/wjd.v15.i6.1367","journal-title":"World J Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.11.013","article-title":"Androgen receptor overexpression in prostate cancer in type 2 diabetes","volume":"8","author":"Lutz SZ","year":"2018","unstructured":"Lutz SZ, Hennenlotter J, Scharpf MO, et al.. Androgen receptor overexpression in prostate cancer in type 2 diabetes. Mol Metab. 2018, 8:158-66. 10.1016\/j.molmet.2017.11.013","journal-title":"Mol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-020-01347-4","article-title":"Examining the relationship between diabetes and prostate cancer through changes in screening guidelines","volume":"31","author":"Miller EA","year":"2020","unstructured":"Miller EA, Pinsky PF. Examining the relationship between diabetes and prostate cancer through changes in screening guidelines. Cancer Causes Control. 2020, 31:1105-13. 10.1007\/s10552-020-01347-4","journal-title":"Cancer Causes Control"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders GJ","year":"2020","unstructured":"van Leenders GJ, van der Kwast TH, Grignon DJ, et al.. The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol. 2020, 44:e87-99. 10.1097\/PAS.0000000000001497","journal-title":"Am J Surg Pathol"},{"key":"ref12","unstructured":"National Comprehensive Cancer Network. NCCN guidelines, prostate cancer. (2025). Accessed: November 5, 2025: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&amp;id=1459."},{"key":"ref13","unstructured":"EAU Guidelines. Prostate cancer. (2025). Accessed: November 5, 2025: https:\/\/uroweb.org\/guidelines\/prostate-cancer."},{"key":"ref14","unstructured":"American Urological Association. Prostate cancer guidelines . (2025). Accessed: November 5, 2025: https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/oncology-guidelines\/prostate-cancer."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0386","article-title":"Association between age at diabetes diagnosis and subsequent incidence of cancer: a longitudinal population-based cohort","volume":"47","author":"Li Y","year":"2024","unstructured":"Li Y, Tian J, Hou T, et al.. Association between age at diabetes diagnosis and subsequent incidence of cancer: a longitudinal population-based cohort. Diabetes Care. 2024, 47:353-61. 10.2337\/dc23-0386","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.01.018","article-title":"The association between age, prostate cancer risk, and higher Gleason score in a long-term screening program: results from the G\u00f6teborg-1 prostate cancer screening trial","volume":"82","author":"Godtman RA","year":"2022","unstructured":"Godtman RA, Kollberg KS, Pihl CG, M\u00e5nsson M, Hugosson J. The association between age, prostate cancer risk, and higher Gleason score in a long-term screening program: results from the G\u00f6teborg-1 prostate cancer screening trial. Eur Urol. 2022, 82:311-7. 10.1016\/j.eururo.2022.01.018","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx742","article-title":"Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study","volume":"29","author":"Pettersson A","year":"2018","unstructured":"Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P. Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol. 2018, 29:377-85. 10.1093\/annonc\/mdx742","journal-title":"Ann Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao Y","year":"2011","unstructured":"Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2011, 4:486-501. 10.1158\/1940-6207.CAPR-10-0229","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23705","article-title":"Serum lipids and prostate cancer","volume":"35","author":"Garrido MM","year":"2021","unstructured":"Garrido MM, Marta JC, Ribeiro RM, Pinheiro LC, Guimar\u00e3es JT. Serum lipids and prostate cancer. J Clin Lab Anal. 2021, 35:e23705. 10.1002\/jcla.23705","journal-title":"J Clin Lab Anal"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.665","article-title":"Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories","volume":"5","author":"Arthur R","year":"2016","unstructured":"Arthur R, M\u00f8ller H, Garmo H, et al.. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories. Cancer Med. 2016, 5:1307-18. 10.1002\/cam4.665","journal-title":"Cancer Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0458","article-title":"Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database","volume":"23","author":"Allott EH","year":"2014","unstructured":"Allott EH, Howard LE, Cooperberg MR, et al.. Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2014, 23:2349-56. 10.1158\/1055-9965.EPI-14-0458","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/1557988319876488","article-title":"Lipid status during combined treatment in prostate cancer patients","volume":"13","author":"Wolny-Rokicka E","year":"2019","unstructured":"Wolny-Rokicka E, Tukiendorf A, Wydma\u0144ski J, Ostrowska M, Zembro\u0144-\u0141acny A. Lipid status during combined treatment in prostate cancer patients. Am J Mens Health. 2019, 13:1557988319876488. 10.1177\/1557988319876488","journal-title":"Am J Mens Health"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2025.200468","article-title":"Associations of low-density lipoprotein cholesterol and hemoglobin A1C with cardiovascular events and mortality in breast and prostate cancer patients","volume":"26","author":"Chen YC","year":"2025","unstructured":"Chen YC, Lu JY, Huang CY, Shao YJ. Associations of low-density lipoprotein cholesterol and hemoglobin A1C with cardiovascular events and mortality in breast and prostate cancer patients. Int J Cardiol Cardiovasc Risk Prev. 2025, 26:200468. 10.1016\/j.ijcrp.2025.200468","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21033","article-title":"The role of androgens in metabolism, obesity, and diabetes in males and females","volume":"23","author":"Navarro G","year":"2015","unstructured":"Navarro G, Allard C, Xu W, Mauvais-Jarvis F. The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring). 2015, 23:713-9. 10.1002\/oby.21033","journal-title":"Obesity (Silver Spring)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0145","article-title":"Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis","volume":"59","author":"Bernal-Soriano MC","year":"2020","unstructured":"Bernal-Soriano MC, Lumbreras B, Hern\u00e1ndez-Aguado I, Pastor-Valero M, L\u00f3pez-Garrigos M, Parker LA. Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis. Clin Chem Lab Med. 2020, 59:11-26. 10.1515\/cclm-2020-0145","journal-title":"Clin Chem Lab Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-007-0050-4","article-title":"Testosterone, diabetes mellitus, and the metabolic syndrome","volume":"8","author":"Spark RF","year":"2007","unstructured":"Spark RF. Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep. 2007, 8:467-71. 10.1007\/s11934-007-0050-4","journal-title":"Curr Urol Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0715","article-title":"Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy","volume":"14","author":"Parsons JK","year":"2005","unstructured":"Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter EJ. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev. 2005, 14:2257-60. 10.1158\/1055-9965.EPI-04-0715","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1114-9","article-title":"A genetic link between type 2 diabetes and prostate cancer","volume":"51","author":"Frayling TM","year":"2008","unstructured":"Frayling TM, Colhoun H, Florez JC. A genetic link between type 2 diabetes and prostate cancer. Diabetologia. 2008, 51:1757-60. 10.1007\/s00125-008-1114-9","journal-title":"Diabetologia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081827","article-title":"The influence of anti-diabetic drugs on prostate cancer","volume":"13","author":"Knura M","year":"2021","unstructured":"Knura M, Garczorz W, Borek A, Drzyma\u0142a F, Rachwa\u0142 K, George K, Francuz T. The influence of anti-diabetic drugs on prostate cancer. Cancers (Basel). 2021, 13:1827. 10.3390\/cancers13081827","journal-title":"Cancers (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.74440","article-title":"Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study","volume":"26","author":"Prabhat P","year":"2010","unstructured":"Prabhat P, Tewari R, Natu SM, et al.. Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study. Indian J Urol. 2010, 26:502-6. 10.4103\/0970-1591.74440","journal-title":"Indian J Urol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00131","article-title":"The metabolic phenotype of prostate cancer","volume":"7","author":"Eidelman E","year":"2017","unstructured":"Eidelman E, Twum-Ampofo J, Ansari J, Siddiqui MM. The metabolic phenotype of prostate cancer. Front Oncol. 2017, 7:131. 10.3389\/fonc.2017.00131","journal-title":"Front Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0902","article-title":"Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study","volume":"19","author":"Meyer TE","year":"2010","unstructured":"Meyer TE, Boerwinkle E, Morrison AC, et al.. Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study. Cancer Epidemiol Biomarkers Prev. 2010, 19:558-65. 10.1158\/1055-9965.EPI-09-0902","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21189","article-title":"Glycemic control and prostate cancer progression: results from the SEARCH database","volume":"70","author":"Kim HS","year":"2010","unstructured":"Kim HS, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. Glycemic control and prostate cancer progression: results from the SEARCH database. Prostate. 2010, 70:1540-6. 10.1002\/pros.21189","journal-title":"Prostate"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.240022","article-title":"Association between diabetes and risk of prostate cancer: a systematic review and meta-analysis of observational studies","volume":"43","author":"Pagano AP","year":"2025","unstructured":"Pagano AP, da Silva BR, Vieira FT, et al.. Association between diabetes and risk of prostate cancer: a systematic review and meta-analysis of observational studies. World J Mens Health. 2025, 43:304-20. 10.5534\/wjmh.240022","journal-title":"World J Mens Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422783-influence-of-diabetes-mellitus-on-metabolic-and-hormonal-interactions-promoting-aggressive-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:53:25Z","timestamp":1762574005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422783-influence-of-diabetes-mellitus-on-metabolic-and-hormonal-interactions-promoting-aggressive-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.96338","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,7]]}}}